To: BUCHAREST STOCK EXCHANGE
FINANCIAL SUPERVISORY AUTHORITY
Report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations
Report Date: 25 February 2021
Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")
Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania
Fax number: 0374 180 470
Unique Registration Code at the National Office of Trade Registry: 8422035
Order number on the Trade Registry: J40/3709/1996
Subscribed and paid-in share capital: 33,217,623 RON
Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category
Significant events to report:
Availability of 2020 Preliminary Financial Results
(period 1 January- 31 December 2020)
for MEDLIFE GROUP and MED LIFE S.A.
Med Life S.A. informs the shareholders and investors that, starting 26 of February 2021, 8:30 AM, on the Company’s website (www.medlifeinternational.com), at section Investor Relations / Investor Reports and Presentations / Annual reports, 2020 Preliminary Financial Results for the period ended December 31, 2020 will be available.
2020 Preliminary Financial Results could also be consulted by accessing the link below.
Website Link : https://www.medlifeinternational.com/investors-reports/annual
For additional information, please contact us at email@example.com, Alina Irinoiu - IR Manager.
The conference call for presenting the 2020 Preliminary Financial Results will take place on February 26, 2021, 15:00 local time. For joining the conference call, please contact us at firstname.lastname@example.org
Chief Executive Officer